Alzheimer's Disease Biomarkers Multiplex Detection Kit

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, accounting for 60-80% of cases. It is characterized by the accumulation of amyloid-beta plaques and neurofibrillary tangles (tau protein) in the brain, leading to neuronal damage, synaptic loss, and brain atrophy. AD faces significant challenges in early diagnosis, particularly during the stages of subjective cogni tive decline (SCD) and mild cognitive impairment (MCI), where atypical symptoms are often over looked. Blood-based biomarker testing, with its advantages of being non-invasive, convenient, and repeatable, offers a breakthrough solution for the early screening, diagnosis, and prognosis of AD.